Has Jonathan Vigdorchik received payments from drug or device companies?

Yes. Drug and device makers reported $2,333,264 in general payments to Jonathan Vigdorchik across 653 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jonathan Vigdorchik did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jonathan Vigdorchik come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jonathan Vigdorchik

Adult Reconstructive Orthopaedic Surgery · New York, NYNPI 1427255876

Payments from drug & device makers

What this record shows

The money is spread across several categories — other (44.7%), consulting fees and royalties or licence payments — rather than concentrated in one kind of arrangement. Depuy Synthes Products, Inc. accounts for 66.0% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2022 at $1,342,018 and has fallen 68.1% since, to $428,734 in 2025. Among adult reconstructive orthopaedic surgery clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,333,264in general payments, 2019–2025

Across 653 payments — averaging $3573.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Depuy Synthes Products, Inc.$1.5M
Zimmer Biomet$346K
Stryker$173K
Medical Device Business Services, Inc.$94K
Omnilife Science, Inc$58K
Corin USA$53K
plus $69K from 12 others

$204,017in research payments, 2019–2025

Across 18 payments — averaging $11,334 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Omnilife Science, Inc$152K
Corin USA$42K
Smith+Nephew$10K

$101,739in ownership & investment interests, 2019–2025

Across 12 payments — averaging $8478.23 each. An ownership or investment interest held by the physician or an immediate family member.

Omnilife Science, Inc$70K
Intellijoint Surgical Inc.$32K

What the payments were for

Royalty or licence$573,06625%
Consulting fees$632,97727%
Speaking & faculty fees$2,7000%
Travel & lodging$68,6733%
Food & beverage$13,3471%
Other$1,042,50045%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Depuy Synthes Products, Inc.	46	$1,541,044
Zimmer Biomet	255	$345,668
Stryker	129	$172,650
Medical Device Business Services, Inc.	90	$93,527
Omnilife Science, Inc	23	$57,883
Corin USA	44	$53,450
Medacta USA, Inc.	14	$48,747
Intellijoint Surgical Inc.	6	$7,260
Globus Medical	5	$5,810
Smith+Nephew	11	$2,797
Pfizer	1	$1,500
Johnson & Johnson	14	$1,071
Alphatec Spine, Inc	1	$1,000
Amgen	9	$598
Encore Medical, LP	1	$150
Si-bone, Inc.	2	$59
Medtronic	1	$27
Molnlycke Health Care US, LLC	1	$21

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,333,264 in reported general payments places this provider in the 95th percentile of 85 adult reconstructive orthopaedic surgery providers in New York.

See all adult reconstructive orthopaedic surgery providers in New York →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Meloxicam	12	$58

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in New York

Seth JerabekNew York$7.1M
Jose RodriguezNew York$3.4M
Friedrich BoettnerNew York$2.9M
William LongNew York$1.5M
Peter SculcoNew York$1.5M
Roshan ShahNew York$1.3M
Herbert CooperNew York$1.3M
Matthew AustinNew York$986K
Patrick MeereNew York$191K
Eytan DebbiNew York$168K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →